VerifiedEvidence: highv1.0.0

Parameter Uncertainty

Uncertainty arising from imperfect knowledge of the true value of an input parameter, such as a transition probability or unit cost.

Last reviewedDarrin Baines IP Ltd

Concept Architecture

Concept


Theoretically, Parameter Uncertainty is the uncertainty arising from imperfect knowledge of the true values of model parameters estimated from finite data. It reflects sampling variability in probabilities, costs, utilities, treatment effects and other model inputs rather than structural uncertainty or population heterogeneity. In health economics, parameter uncertainty is explicitly quantified because uncertainty in estimated inputs propagates through decision models and influences estimates of cost-effectiveness.

Mathematically, parameter uncertainty is represented by assigning probability distributions to uncertain model parameters. The distributions are parameterised using estimates obtained from empirical data and their associated measures of variability, such as standard errors or confidence intervals. Uncertainty is propagated through the model using probabilistic simulation, producing a distribution of model outcomes rather than a single point estimate.

In practice, parameter uncertainty is evaluated using probabilistic sensitivity analysis, in which repeated random sampling from parameter distributions generates distributions of costs, health outcomes and incremental cost-effectiveness ratios. The resulting simulations are summarised using cost-effectiveness acceptability curves, confidence intervals and expected net monetary benefit to support health technology assessment and reimbursement decisions.


Purpose


Used to quantify the impact of uncertainty in estimated model parameters on health economic outcomes, thereby assessing the robustness of cost-effectiveness conclusions and informing decision-making under uncertainty.


Mathematical Formulae

Primary Formula

? ~ D(?, ��)

where:

  • ? = uncertain model parameter
  • D = probability distribution
  • ? = estimated parameter value
  • �� = parameter variance

Supporting Formulae

Expected value:

E(?) = ?

Variance:

Var(?) = ��

Incremental Net Monetary Benefit:

INMB = ? ? ?E ? ?C

Monte Carlo expectation:

E(Y) � (1/N) ? ?Y?

Related Mathematical Methods

  • Probabilistic Sensitivity Analysis
  • Monte Carlo Simulation
  • Bayesian Analysis
  • Maximum Likelihood Estimation
  • Bootstrapping
  • Cost-Effectiveness Acceptability Curve

Example


A health economic model estimates the probability of treatment success as 0.78 with a standard error of 0.04.

The parameter is assigned a Beta distribution:

? ~ Beta(67,19)

During probabilistic sensitivity analysis, 10,000 Monte Carlo simulations sample values from this distribution. The resulting distribution of incremental costs and QALYs is used to estimate the probability that the intervention is cost-effective at a willingness-to-pay threshold of �30,000 per QALY.


Excel Implementation

FunctionExample FormulaHealth Economics Application
RAND=RAND()Generate random values for simulation
BETA.INV=BETA.INV(RAND(),67,19)Sample uncertain probabilities
NORM.INV=NORM.INV(RAND(),Mean,SD)Sample normally distributed parameters
GAMMA.INV=GAMMA.INV(RAND(),Shape,Scale)Sample healthcare costs
AVERAGE=AVERAGE(ResultRange)Estimate expected model outcomes across simulations

VBA (Optional)


A VBA procedure can automate probabilistic sensitivity analysis by repeatedly sampling parameter distributions, recalculating the model and summarising simulation outputs.


Sources

  • Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation.
  • Drummond MF, et al. Methods for the Economic Evaluation of Health Care Programmes.
  • ISPOR-SMDM Modeling Good Research Practices Task Force Reports.
  • NICE. Health Technology Evaluation Manual.
  • Fenwick E, Claxton K, Sculpher M. Representing Uncertainty: The Role of Cost-Effectiveness Acceptability Curves.

Library

Publications

1
  • Journal article

    Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6 — Briggs, Weinstein, Fenwick, Karnon, Sculpher & Paltiel, Task Force Report 6 ed., 2012 (Value in Health / Medical Decision Making)

    Best-practice guidance on parameter estimation and the characterisation of uncertainty in decision models, covering probabilistic sensitivity analysis, distributional choices, and correlation between parameters.

Frequently Asked Questions (6)

  • What is parameter uncertainty?

    Uncertainty arising from imperfect knowledge of the true value of an input parameter, such as a transition probability or unit cost.

    Source: Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford University Press; 2006. doi:10.1093/oso/9780198526629.001.0001.

  • Why is parameter uncertainty reducible in principle?

    Parameter uncertainty stems from imperfect knowledge of a true underlying value, such as a transition probability or unit cost, which is fixed but not precisely known. Because it reflects a gap in knowledge rather than genuine variation, gathering more or better data narrows it, and with enough evidence it could in principle be removed. This distinguishes it from variability between individuals, which more data describes but cannot eliminate. Its reducibility is what makes further research potentially worthwhile. Briggs and colleagues (2006) draw this distinction.

    Source: Briggs et al. 2006

  • How is parameter uncertainty represented?

    Parameter uncertainty is represented by assigning each uncertain parameter a probability distribution that reflects the range and likelihood of its plausible true values, given the evidence, and then sampling from these distributions in probabilistic sensitivity analysis. Running the model over many samples produces a distribution of results conveying how parameter uncertainty propagates to the output. The distributions are chosen to suit each parameter's nature and set from its data, so that the represented uncertainty reflects the precision with which each parameter is known.

    Source: Briggs, Claxton & Sculpher 2006

  • How does parameter uncertainty differ from other uncertainty?

    Parameter uncertainty, imperfect knowledge of the true parameter values, differs from first-order or individual-level variability, which is the random variation between individuals present even if parameters were known, and from methodological or structural uncertainty, which concerns choices of methods and model structure. Parameter uncertainty can be reduced by more data and is represented by distributions on the parameters, whereas individual variability averages out for a population decision and methodological uncertainty is explored by scenario analysis. Distinguishing these clarifies what drives decision uncertainty and how each is handled.

    Source: Drummond et al. 2015

  • Why does parameter uncertainty matter?

    Parameter uncertainty matters because it determines how confident one can be in a model's results and hence in the decision, since imprecise parameter values lead to uncertain outputs that may span different conclusions. Characterising it through probabilistic analysis shows the probability that an intervention is cost-effective and where the uncertainty is greatest, informing both the decision and whether further research is worthwhile. Ignoring parameter uncertainty would give a false sense of precision, so representing it is central to a credible economic evaluation.

    Source: Briggs, Claxton & Sculpher 2006

  • How can parameter uncertainty be reduced?

    Parameter uncertainty can be reduced by collecting more or better evidence on the uncertain parameters, since it stems from limited data, so larger studies or additional research narrow the distributions around the true values. Value-of-information analysis helps identify which parameters are worth researching further, by valuing the reduction in uncertainty in terms of better decisions. Focusing data collection on the influential, uncertain parameters is the efficient way to reduce parameter uncertainty, in contrast to individual variability, which reflects genuine variation and is not reduced by more data.

    Source: Briggs, Claxton & Sculpher 2006

Trust Record

Verified by Dr Darrin Baines

British health economist

Professional identity: darrinbaines.org

Verification date: 29 Oct 2025

Content version: 1.0.0

Canonical Identity

Term code
HE-EM-UA-052

Stable URI · Machine-readable · Resolvable · CC BY 4.0